The Economy

[Lazaran]

Very well said. Should be a hard slap in the face to our gutless leaders.

And every bit of the housing problem (and other problems) is on the empty heads of the imbeciles that voted for DonOld & the MAGAt republican "leaders" and their destructive policies.



We. Told. Them. So.

 

[BabyBoomer50s]

The rescission bill to incorporate Doge savings is forthcoming.

One (very) small step for man, one (modest) leap for mankind.

Live updates: House approves Trump’s $9 billion cut to public broadcasting and foreign aid​

https://apnews.com/live/donald-trump-news-updates-7-18-2025

 

[butters]

Texas just took a major economic hit.

Three large factories shut down without much warning, and the timing couldn’t be worse.

Recent reports from the Federal Reserve Bank of Dallas show that the state’s economy is losing steam fast – from manufacturing and retail to service jobs and beyond.

https://www.msn.com/en-us/money/mar...6fd19f72b14cfebaa85d4c54c3b6a0&ei=140#image=1

 

[butters]

White House budget chief says he's 'having fun' as crucial cancer research axed​

President Donald Trump's chief at the Office of Management and Budget, Russ Vought, confessed that he's enjoying making drastic cuts as his office slashes funding for things like medical research into cures for diseases like cancer and Alzheimer's.

"He cited the National Institutes of Health, which is currently the premier biomedical research institution in the world, as one agency that 'needs fundamental reform,'" she noted. "The agency has already lost at least 1,200 employees and faces a proposed 40% cut to its budget under the Trump administration."

When Vought was asked what he meant by "having fun," he answered, "What's not fun?"

 

[heathrowinneo]

White House budget chief says he's 'having fun' as crucial cancer research axed​

Vought and company are despicable and his former organization should be labeled as a terrorist organization.

The cost of the cuts will far exceed any savings.

 

[dmallord]

Warnings about the housing market are growing more dire. It points to that dreaded R word... Recession.

Housing Market News

 

[1984X2024]

https://twitter.com/x/status/1946909368374480930

 

[MajorRewrite]

https://twitter.com/x/status/1946909368374480930

Mentally disabled 86TintaNoitx2024 shares more ridiculous propaganda from its Xitter feed.

It needs to find a better source for its “thoughts”.

 

[subdudeme13]

Trying to reason with MAGAts is like pissing into the ocean trying to raise the tide.

 

[MajorRewrite]

Warnings about the housing market are growing more dire. It points to that dreaded R word... Recession.

Housing Market News

That’s a good read. Comprehensive data.

 

[dmallord]

Trump couldn’t get Mexico to fund a southern border wall, but somehow managed to bankroll Canada’s northern trade wall—one that politely keeps American businesses out, paid for by U.S. tariffs. Canada’s got their own wall now—quietly built with Trump’s tariffs and our wallets.

A funny thing: Taco Trump still doesn’t have any of those “reciprocal tariffs” fully agreed upon and solidly in place. He’s waved executive orders around, pushed deadlines to August 1, sued courts, and basically, we’re all paying higher prices, but no concrete tariff wall actually stands. Meanwhile, Canada quietly rewrote a few lines, locked U.S. firms out of federal contracts, and never made a scene.

So yes, brag away about tariff revenue—but remember, it’s money drained from our pockets to fund… what exactly? An invisible border wall—but it's not on the map where MAGA thought it’d be.

 

[1984X2024]

Mentally disabled 86TintaNoitx2024 shares more ridiculous propaganda from its Xitter feed.

It needs to find a better source for its “thoughts”.

Toldya the BLS is Deep State and not credible

Cause they are the source of the stat

 

[BabyBoomer50s]

Today’s surprise headline from the Wall Street Journal. Surprising because Taco has more than quadrupled the average US tariff rate since “Liberation Day.”

The Global Economy Is Powering Through a Historic Increase in Tariffs
Trade, production, growth and other global economic vitals are proving resilient almost four months after President Trump’s ‘Liberation Day’ tariffs

Trade volumes are buoyant, stock markets on both sides of the Atlantic have rebounded to record highs and growth forecasts from Europe to Asia are being raised.
Investment, manufacturing employment, spending and overall activity all held up globally, according to Goldman Sachs.

 

[MajorRewrite]

Toldya the BLS is Deep State and not credible

Cause they are the source of the stat

You keep telling us that the Trump administration is lying. You are mentally disabled.

 

[MajorRewrite]

Today’s surprise headline from the Wall Street Journal. Surprising because Taco has more than quadrupled the average US tariff rate since “Liberation Day.”

The Global Economy Is Powering Through a Historic Increase in Tariffs
Trade, production, growth and other global economic vitals are proving resilient almost four months after President Trump’s ‘Liberation Day’ tariffs

Trade volumes are buoyant, stock markets on both sides of the Atlantic have rebounded to record highs and growth forecasts from Europe to Asia are being raised.
Investment, manufacturing employment, spending and overall activity all held up globally, according to Goldman Sachs.

The Fake Conservative continues to celebrate tariffs taking money from American businesses and citizens.

TACO did TACO on most of his tariffs, so it’s not surprising that the impact has been muted. August 1 is the new date that TACO might implement his promised taxes on American consumers, unless TACO TACOs again. So far, the stock markets are betting that TACO will always TACO.

Meanwhile, inflation has gone up in each of the last two months.

 

[MajorRewrite]

TrumpTariffs took a $1.1 billion bite from GM’s profits.

General Motors' second-quarter core profit fell 32% to $3 billion on Tuesday, as the automaker continued to confront challenging tariff policies, which it said sapped $1.1 billion from the results.

The largest U.S. automaker by sales said it expects the tariff impact to worsen in the third quarter and stuck to a previous estimate that trade headwinds threaten to hit the bottom line by $4 billion to $5 billion.

Trump’s new taxes on American businesses and consumers have an impact, despite what sheep try to tell us.

 

[1984X2024]

BRING IT ON HOME: AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D.

AstraZeneca today announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs across the country powering growth and delivering next generation medicines for patients in America and worldwide.
The cornerstone of this landmark investment is a new multi-billion dollar US manufacturing facility that will produce drug substances for the Company’s innovative weight management and metabolic portfolio, including oral GLP-1, baxdrostat, oral PCSK9 and combination small molecule products. The new state-of-the-art centre will produce small molecules, peptides and oligonucleotides. This multi-billion dollar capital investment is in addition to the $3.5 billion announced in November 2024.

 

[MajorRewrite]

This multi-billion dollar capital investment is in addition to the $3.5 billion announced in November 2024.

It’s excellent that AstraZeneca continues to invest in the US, as it did before.

 

[1984X2024]

no prior ACTUAL $$ INVESTMENT in teh US past 20 yrs except under Trump

AstraZeneca has made significant investments in the United States over the past 20 years, particularly in recent years. Here's a breakdown of their investments:
Major Investment Announcements:

• $50 Billion Investment (Announced July 2025): AstraZeneca plans to invest a massive $50 billion in the US by 2030, with a focus on manufacturing and research and development (R&D). This includes:
  • New Manufacturing Facility in Virginia: A multi-billion dollar facility for producing drug substances, specifically for chronic diseases and weight loss treatments. This will be AstraZeneca's largest single manufacturing investment globally.
  • Expansion of R&D Capabilities: Expanding existing R&D facilities in Gaithersburg, Maryland, and establishing a new R&D center in Cambridge, Massachusetts.
  • New Cell Therapy Manufacturing Facilities: Developing facilities in Rockville, Maryland, and Tarzana, California.
  • Upgrades to Existing Manufacturing Sites: Expanding continuous manufacturing in Mount Vernon, Indiana, and specialty manufacturing in Coppell, Texas.
  • New Clinical Trial Supply Sites: Creating new locations to support clinical trials.
• $3.5 Billion Investment (Announced November 2024): This earlier investment focused on expanding an R&D center in Cambridge, Massachusetts, developing a biologics manufacturing facility in Maryland, and enhancing specialty manufacturing capabilities in Texas.

Other Investments and Activities:

• Acquisitions: In 2007, AstraZeneca acquired Arrow Therapeutics and MedImmune, strengthening their antiviral and biologics pipeline. In 1994 and 1997, before the past 20 years but important for historical context, Zeneca (pre-merger) acquired Salick Health Care, increasing its focus on oncology.
• AI Partnerships: AstraZeneca has actively partnered with AI development companies and utilized AI platforms to discover and develop new drug targets, particularly in oncology and neurodegenerative diseases.
• Academic and Research Collaborations: AstraZeneca has engaged in partnerships with academic institutions, such as the Stanford Center for Clinical Research and the Yale-AstraZeneca Oncology Alliance, to advance research and address health challenges.
• Population Screening Initiatives: Working with organizations like the Greenbaum Cancer Center at the University of Maryland Cancer Hospitals to utilize AI for population screening.
• Clinical Trial Infrastructure: Partnering to expand clinical trial access and awareness, such as through the AIRE Mobile Unit program with IQVIA.

Context for the Investments:

• These investments reflect the United States being AstraZeneca's largest market.
• They aim to strengthen the US supply chain and reduce reliance on foreign-made pharmaceuticals, particularly in response to potential tariffs on drug imports.
• The investments are expected to create numerous jobs and contribute significantly to the US economy.

 

[MajorRewrite]

no prior ACTUAL $$ INVESTMENT in teh US past 20 yrs except under Trump

AstraZeneca has made significant investments in the United States over the past 20 years, particularly in recent years. Here's a breakdown of their investments:
Major Investment Announcements:

• $50 Billion Investment (Announced July 2025):AstraZeneca plans to invest a massive $50 billion in the US by 2030, with a focus on manufacturing and research and development (R&D). This includes:
  • New Manufacturing Facility in Virginia: A multi-billion dollar facility for producing drug substances, specifically for chronic diseases and weight loss treatments. This will be AstraZeneca's largest single manufacturing investment globally.
  • Expansion of R&D Capabilities: Expanding existing R&D facilities in Gaithersburg, Maryland, and establishing a new R&D center in Cambridge, Massachusetts.
  • New Cell Therapy Manufacturing Facilities: Developing facilities in Rockville, Maryland, and Tarzana, California.
  • Upgrades to Existing Manufacturing Sites: Expanding continuous manufacturing in Mount Vernon, Indiana, and specialty manufacturing in Coppell, Texas.
  • New Clinical Trial Supply Sites: Creating new locations to support clinical trials.
• $3.5 Billion Investment (Announced November 2024): This earlier investment focused on expanding an R&D center in Cambridge, Massachusetts, developing a biologics manufacturing facility in Maryland, and enhancing specialty manufacturing capabilities in Texas.

Other Investments and Activities:

• Acquisitions: In 2007, AstraZeneca acquired Arrow Therapeutics and MedImmune, strengthening their antiviral and biologics pipeline. In 1994 and 1997, before the past 20 years but important for historical context, Zeneca (pre-merger) acquired Salick Health Care, increasing its focus on oncology.
• AI Partnerships: AstraZeneca has actively partnered with AI development companies and utilized AI platforms to discover and develop new drug targets, particularly in oncology and neurodegenerative diseases.
• Academic and Research Collaborations: AstraZeneca has engaged in partnerships with academic institutions, such as the Stanford Center for Clinical Research and the Yale-AstraZeneca Oncology Alliance, to advance research and address health challenges.
• Population Screening Initiatives: Working with organizations like the Greenbaum Cancer Center at the University of Maryland Cancer Hospitals to utilize AI for population screening.
• Clinical Trial Infrastructure: Partnering to expand clinical trial access and awareness, such as through the AIRE Mobile Unit program with IQVIA.

Context for the Investments:

• These investments reflect the United States being AstraZeneca's largest market.
• They aim to strengthen the US supply chain and reduce reliance on foreign-made pharmaceuticals, particularly in response to potential tariffs on drug imports.
• The investments are expected to create numerous jobs and contribute significantly to the US economy.

Your original quote had this as the final line:

“This multi-billion dollar capital investment is in addition to the $3.5 billion announced in November 2024.”

It’s an announcement, exactly like the announcement you’re hyping up. You truly are remarkably mentally disabled.

 

[dmallord]

no prior ACTUAL $$ INVESTMENT in teh US past 20 yrs except under Trump

But you copied and pasted this blurb that says it made significant investments in the past twenty years. I take it the second statement, from the manufacturer's spin, is more accurate than your first one about ONLY under the felon?

You can't prop up Trump by citing CHAT.gpt info that contradicts your own words, Bubba.

AstraZeneca has made significant investments in the United States over the past 20 years, particularly in recent years. Here's a breakdown of their investments:
Major Investment Announcements:

• $50 Billion Investment (Announced July 2025):AstraZeneca plans to invest a massive $50 billion in the US by 2030, with a focus on manufacturing and research and development (R&D). This includes:
  • New Manufacturing Facility in Virginia: A multi-billion dollar facility for producing drug substances, specifically for chronic diseases and weight loss treatments. This will be AstraZeneca's largest single manufacturing investment globally.
  • Expansion of R&D Capabilities: Expanding existing R&D facilities in Gaithersburg, Maryland, and establishing a new R&D center in Cambridge, Massachusetts.
  • New Cell Therapy Manufacturing Facilities: Developing facilities in Rockville, Maryland, and Tarzana, California.
  • Upgrades to Existing Manufacturing Sites: Expanding continuous manufacturing in Mount Vernon, Indiana, and specialty manufacturing in Coppell, Texas.
  • New Clinical Trial Supply Sites: Creating new locations to support clinical trials.
• $3.5 Billion Investment (Announced November 2024): This earlier investment focused on expanding an R&D center in Cambridge, Massachusetts, developing a biologics manufacturing facility in Maryland, and enhancing specialty manufacturing capabilities in Texas.

Other Investments and Activities:

• Acquisitions: In 2007, AstraZeneca acquired Arrow Therapeutics and MedImmune, strengthening their antiviral and biologics pipeline. In 1994 and 1997, before the past 20 years but important for historical context, Zeneca (pre-merger) acquired Salick Health Care, increasing its focus on oncology.
• AI Partnerships: AstraZeneca has actively partnered with AI development companies and utilized AI platforms to discover and develop new drug targets, particularly in oncology and neurodegenerative diseases.
• Academic and Research Collaborations: AstraZeneca has engaged in partnerships with academic institutions, such as the Stanford Center for Clinical Research and the Yale-AstraZeneca Oncology Alliance, to advance research and address health challenges.
• Population Screening Initiatives: Working with organizations like the Greenbaum Cancer Center at the University of Maryland Cancer Hospitals to utilize AI for population screening.
• Clinical Trial Infrastructure: Partnering to expand clinical trial access and awareness, such as through the AIRE Mobile Unit program with IQVIA.

Context for the Investments:

• These investments reflect the United States being AstraZeneca's largest market.
• They aim to strengthen the US supply chain and reduce reliance on foreign-made pharmaceuticals, particularly in response to potential tariffs on drug imports.
• The investments are expected to create numerous jobs and contribute significantly to the US economy.

 

[Rightguide]

How Trump’s Economy Continues To Defy The ‘Experts’ And Shock The ‘Panicans’​

For the "experts," the rapid pace of the administration's economic agenda has been shocking. For President Trump, this was all a part of the plan.
By Zach Jewell
•
Jul 21, 2025 DailyWire.com
https://dw-wp-production.imgix.net/2025/07/Donald-Trump-10-scaled-e1753115678636.jpg?ar=16%3A9&auto=compress&crop=faces&cs=origin&fit=crop&w=1035?ar=16:9&fit=crop&crop=faces&fm=webpAFP via Getty Images

In the first six months of President Donald Trump’s second term, one major theme has defined Trump’s economic record thus far: success that surprises the people who are paid to predict it.

It hasn’t been surprising for the president, who is carrying out his promise to revamp American manufacturing and boost American jobs, mainly by imposing unprecedented tariffs on nearly every country in the world. And it comes as economists who predicted large-scale inflation and market downturn over Trump’s bold economic agenda keep seeing economic metrics come across their desks showing the opposite.

Earlier this year, Americans were told to brace their wallets for rising inflation and prepare for a recession caused by Trump’s major tariffs, especially those levied on America’s biggest trading partners, China, Canada, and Mexico. In May, Goldman Sachs analysts said core goods inflation could hit 6.3% by the end of the year while consumer prices would spike 3.7% by early 2026, according to CNN.

The latest numbers on the U.S. economy fly in the face of the naysayers, branded by Trump as “panicans.” Late last week, the U.S. Census Bureau reported that June retail sales were up 0.6% from May and up 3.5% from last year. Food service and drinks sales jumped 6.6% from June 2024. Those numbers were, of course, better than what economists had predicted — a phrase that has become a monthly tradition since Trump stepped back into the White House

More here: https://www.dailywire.com/news/how-...es-to-defy-the-experts-and-shock-the-panicans

MajorRewrite should change her name to Private Revision.

 

[1984X2024]

But you copied and pasted this blurb that says it made significant investments in the past twenty years. I take it the second statement, from the manufacturer's spin, is more accurate than your first one about ONLY under the felon?

You can't prop up Trump by citing CHAT.gpt info that contradicts your own words, Bubba.

YOU ARENT VERY BRIGHT!

 

[MajorRewrite]

How Trump’s Economy Continues To Defy The ‘Experts’ And Shock The ‘Panicans’​

For the "experts," the rapid pace of the administration's economic agenda has been shocking. For President Trump, this was all a part of the plan

MajorRewrite should change her name to Private Revision.

Actual economic data I’ve shared in this thread:

• Inflation increased in each of the last two months.
• New home starts and permits are down, and the inventory of unsold new homes has grown to 2007 levels.
• Trump tariffs took $300 billion from American businesses and consumers so far.
• Unemployment continued claims are rising.
• The cost of gasoline is up since Trump took office.
• The cost of electricity is up since Trump took office, due to the rising price of natural gas.
• Tariffs reduced GM’s quarterly profit by $1.1 billion.
• Retail sales rebounded in June from a decline in May.
• The unemployment rate has remained at an impressively low level since December 2021.
• Stock market gains were basically zero for the first 6 months of the year.

You can pretend everything is coming up roses, but I prefer real facts.

 

[dmallord]

YOU ARENT (sic) VERY BRIGHT!

Observant enough to spot your false claim and failure to source your references. It doesn't take much to point out glaring falsehoods. I've had lots of practice spotting those in Trump's daily dosages.